Nodular prurigo responds to cyclosporin.
Nodular prurigo is a distressing disease which is difficult to treat. Two patients with severe nodular prurigo were treated with cyclosporin for periods of 36 and 24 weeks, respectively, using doses of 3-4.5 mg/kg per day. In both cases there was a reduction in the severity of pruritus after 2 weeks of treatment. In one patient there was a considerable, although incomplete response, and in the other almost complete resolution of the disease was achieved. The improvement was maintained throughout the treatment period, and the drug was generally well tolerated, although in one patient there was a rise in serum creatinine during treatment, which later returned to normal.
Berth-Jones
J
J
Department of Dermatology, Leicester Royal Infirmary, U.K.
Smith
S G
SG
Graham-Brown
R A
RA
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011536:Prurigo / Q000188:drug therapy* / Q000473:pathology
D016572:Cyclosporine